Back to Results
First PageMeta Content
Clinical research / Pharmacology / Medical statistics / Design of experiments / Evaluation methods / Multiple myeloma / Bortezomib / Panobinostat / End point of clinical trials / Medicine / Research / Science


NDA[removed]panobinostat (Farydak) ODAC Brief FDA Briefing Document
Add to Reading List

Open Document

File Size: 3,18 MB

Share Result on Facebook
UPDATE